Vivo Infusion Welcomes New Leadership with Stephan Rodgers
Vivo Infusion, a prominent provider dedicated to effective ambulatory infusion services, proudly announces the appointment of Stephan Rodgers as the new Chief Executive Officer. This strategic move marks a pivotal moment for the company as it continues to solidify its position in the healthcare industry.
A Vision for Ambulatory Infusion Services
Stephan Rodgers joins Vivo Infusion after an impressive tenure at AccentCare, where he played a critical role in the company’s growth. Under his leadership, AccentCare expanded from 60 to over 250 locations across multiple states, serving more than 60,000 patients on a daily basis. His depth of experience in the healthcare arena positions him well to lead Vivo Infusion in its mission to provide accessible treatment options for patients.
Bridging the Leadership Transition
The transition of leadership was thoughtfully planned, ensuring a seamless handover from outgoing CEO Chris Reef to Stephan Rodgers. Chris Reef, who now assumes the role of Executive Chairman, is optimistic about the future under Rodgers' guidance. He remarks, “With his dedication to patient care and extensive healthcare knowledge, Steve is perfectly poised to lead Vivo Infusion into its next chapter.”
Rodgers’ Commitment to Patient Care
Steve's journey in healthcare began as a clinician, and he has dedicated over three decades to enhancing patient well-being. He emphasized his eagerness to drive Vivo Infusion’s service excellence, stating, “Joining Vivo is an honor, and I look forward to guiding the company towards even greater success.” His passion for patient-centered care aligns seamlessly with Vivo's core values.
A Growing Provider in Ambulatory Infusion
Renowned for offering community-based infusion and injection care, Vivo Infusion has established itself as a leader for patients dealing with cancer and immune system challenges. With an expanding footprint across numerous states, Vivo is set to broaden its reach, making a difference in more communities. The focus on providing efficient and compassionate care remains paramount, ensuring that every patient receives the support they need.
Expressing Gratitude to Chris Reef
As the leadership transitions, Vivo Infusion's employees and stakeholders extend heartfelt appreciation to Chris Reef for his dedication and impact during his tenure as CEO. His visionary leadership has paved the way for ongoing growth and innovation.
Frequently Asked Questions
Who is the new CEO of Vivo Infusion?
Stephan Rodgers has been appointed as the new CEO of Vivo Infusion, succeeding Chris Reef.
What position did Chris Reef take after stepping down as CEO?
Chris Reef transitioned to the role of Executive Chairman following his term as CEO.
What is Vivo Infusion's mission?
Vivo Infusion aims to provide accessible and compassionate infusion and injection care for patients facing various health challenges.
What experience does Stephan Rodgers bring to Vivo Infusion?
Rodgers brings extensive healthcare leadership experience, most recently serving as CEO at AccentCare.
How is Vivo Infusion planning to expand its services?
Vivo Infusion is set to extend its reach by entering additional markets, continuing its commitment to patient care.
